Investors Sue Integer (ITGR) Over Heart Device Claims

A class action lawsuit has been filed against Integer Holdings Corporation (ITGR) alleging that investors purchased stock at artificially inflated prices between July 25, 2024, and October 22, 2025. The lawsuit claims that Integer and its senior officers deceived investors by omitting crucial information regarding the demand for their electrophysiology (EP) devices and other related issues in SEC filings. Specifically, the plaintiffs allege that company executives made false and misleading statements during earnings calls, claiming their EP business was growing faster than the market, when this was not the case.

The lawsuit was triggered by Integer’s announcement on October 23, 2025, where they significantly lowered their full-year 2025 guidance and projected slower sales growth for 2026, citing slower-than-expected adoption of two of their devices. This announcement led to a substantial drop in the company’s stock price. The plaintiffs, including the West Palm Beach Firefighters’ Pension Fund, are seeking compensation for financial losses incurred as a result of the alleged misconduct.

Integer is a medical device company specializing in products for heart conditions, cancer, and other diseases, with approximately 11,000 employees and operations across multiple countries. The core of the dispute centers around the Cardio & Vascular segment, particularly the EP devices used to diagnose and treat irregular heartbeats.

(Source：Markets Insider)